estradiol valerate 1mg tablets
de pharmaceuticals - estradiol valerate - oral tablet - 1mg
estradiol valerate 1mg tablets
bayer plc - estradiol valerate - oral tablet - 1mg
estradiol valerate 1mg tablets
sigma pharmaceuticals plc - estradiol valerate - oral tablet - 1mg
qlaira film-coated tablet
bayer co. (malaysia) sdn. bhd. - dienogest; dienogest; estradiol valerate; estradiol valerate; estradiol valerate; estradiol valerate -
progyluton tablets
bayer co. (malaysia) sdn. bhd. - estradiol valerate; estradiol valerate; norgestrel -
climen 28 sugar coated tablet
bayer co. (malaysia) sdn. bhd. - estradiol valerate; estradiol valerate; cyproterone acetate -
depo-estradiol- estradiol cypionate injection
physicians total care, inc. - estradiol cypionate (unii: 7e1dv054lo) (estradiol cypionate - unii:7e1dv054lo) - estradiol cypionate 5 mg in 1 ml - depo-estradiol injection is indicated in the treatment of: - moderate to severe vasomotor symptoms associated with the menopause. - hypoestrogenism due to hypogonadism. estrogens should not be used in individuals with any of the following conditions: - undiagnosed abnormal genital bleeding. - known or suspected cancer of the breast. - known or suspected estrogen-dependent neoplasia. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). - liver dysfunction or disease. - depo-estradiol should not be used in patients with known hypersensitivity to its ingredients. - known or suspected pregnancy. there is no indication for depo-estradiol in pregnancy. there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy. (see precautions.) chlorobu
depo-estradiol- estradiol cypionate injection
pharmacia & upjohn company llc - estradiol cypionate (unii: 7e1dv054lo) (estradiol - unii:4ti98z838e) - estradiol cypionate 5 mg in 1 ml - depo-estradiol injection is indicated in the treatment of: estrogens should not be used in individuals with any of the following conditions: there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy. (see precautions.) chlorobutanol anhydrous (chloral derivative) added as a preservative may be habit forming.
estradiol valerate 2mg / levonorgestrel 75microgram tablets
bayer plc - estradiol valerate; levonorgestrel - oral tablet - 2mg ; 75microgram
estradiol valerate 2mg / norgestrel 500microgram tablets
viatris uk healthcare ltd - estradiol valerate; norgestrel - oral tablet - 2mg ; 500microgram